Thursday, April 6, 2017

Cannabis Stock News: ICC International Cannabis Corporation (TSX VENTURE: $ICC) Included in First Medical #Marijuana #ETF - (TSX: $HMMJ)

Cannabis Stock News: ICC International Cannabis Corporation (TSX VENTURE: $ICC) Included in First Medical #Marijuana #ETF - (TSX: $HMMJ)

Vancouver, British Columbia - April 6, 2017 (Investorideas.com Newswire) ICC International Cannabis Corporation (TSX VENTURE:ICC) ("ICC" or the "Company") is pleased to announce that it has been included in the Horizons Medical Marijuana Life Sciences ETF (TSX:HMMJ). The Company represented approximately 2.1% of the index weight as at market close on April 5, 2017.
The North American Marijuana Index tracks the leading public cannabis companies operating in the United States and Canada and gives investors up to date, centralized news on the securities deemed to be well positioned within the multi-billion dollar cannabis industry. Selected companies must meet stringent trading guidelines including having a minimum market capitalization of $30 million and daily trading volumes of above $400K.
"We are delighted to have Abattis added to the The Marijuana Index and look forward to sharing our story with investors closely tracking this exciting sector," stated Abattis CFO, Rene David. "As we approach sector legalization, we'll start to see markets broaden their reach from the closely covered cultivation and growing players to those advancing the technology and biosciences side of the cannabis industry," added Mr. David.
Abattis' subsidiary Northern Vine Labs is set to open its doors this month and will legally be able to test dried plant products, extracts, derivatives and edibles for licensed producers and patients under the ACMPR regulatory framework. Management will continue to provide timely updates on these developments in the coming weeks.
About Abattis Bioceuticals Corp.
Abattis is a specialty agricultural technology and biotechnology company which aggregates, integrates, and invests in agricultural technologies and biotechnology services for the legal cannabis industry developing in Can"The establishment of the first medical marijuana ETF is an important milestone for the cannabis industry as a whole and specifically for ICC. In a fast changing industry, we believe this ETF is a significant vote of confidence for this up and coming asset class," commented Guillermo Delmonte, Chief Executive Officer of the Company. "As a producer of cannabis with operations outside of Canada, being included in the ETF serves as another layer of credibility for the Company."
To be eligible for inclusion in this ETF, issuers must meet certain minimum asset, market capitalization and liquidity thresholds.
ABOUT ICC INTERNATIONAL CANNABIS CORPORATION
The Company has operations in Uruguay, and is focused on the licensed production, development and sale of recreational cannabis, cannabinoid extracts and by-products for medicinal uses and industrial hemp. For more information, please see www.intcannabiscorp.com.
Neither the TSX Venture Exchange ("TSXV") nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this release.
Certain information in this press release may constitute forward-looking information. This information is based on current expectations that are subject to significant risks and uncertainties that are difficult to predict, including the Company's ability to obtain any requisite regulatory approvals. Actual results might differ materially from results suggested in any forward-looking statements. The Company assumes no obligation to update the forward-looking statements, or to update the reasons why actual results could differ from those reflected in the forward looking-statements unless and until required by securities laws applicable to the Company. Additional information identifying risks and uncertainties is contained in the Company's filings with Canadian securities regulators, which filings are available at www.sedar.com.
Contact Information
ICC International Cannabis Corporation
Guillermo Delmonte
Chief Executive Officer and Director
598-2900-0000
ir@intcannabiscorp.com
www.intcannabiscorp.com


Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video


 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


Wednesday, April 5, 2017

Strainprint Technologies Launches Revolutionary New Mobile App For Cannabis Patients

Strainprint Technologies Launches Revolutionary New Mobile App For Cannabis Patients


TORONTO - April 5, 2017 (Investorideas.com Newswire) StrainprintTM Technologies Ltd. ("StrainprintTM") -- a leader in cannabis patient data collection -- is proud to announce the commercial launch of a revolutionary Cannabis Tracking APP & platform. The mobile APP is free for patients and is available for both Apple iOS & Android.
StrainprintTM enables cannabis patients to track and understand the efficacy of their cannabis use by strain, quantity, method of ingestion and dose. Using standardized pain scales, this much-needed data will help patients use cannabis more effectively and help clinicians to better tailor therapeutic regimens. Strainprint's database contains all strains and products available under the Access to Cannabis for Medical Purposes Regulations program (ACMPR). Patients can also add their own unique/personal strains.
"StrainprintTM will help patients and medical practitioners to better understand how specific cannabis genetics and ingestion methods provide the best therapy for over 170 applicable medical conditions," said Alexander Repetski, Chief Communications Officer. "By using individuals' data to fine-tune their treatment, StrainprintTM will assist in improving the quality of life for those using cannabis. This data is also needed by the academic community to accelerate research efforts and to further enhance the understanding of cannabis," he added.
The HIPAA and PIPEDA compliant solution is already identifying valuable and fascinating efficacy trends across a variety of medical conditions. This information will enable patients, producers, clinicians and other supply chain partners to better understand the needs of patients and how specific cannabinoids effect a multitude of conditions.
"The importance of this real-time crowd-sourced data is integral to both governmental bodies and the academic community to accelerate research efforts and further enhance the understanding of cannabis," said StrainprintTM President, David Berg. "With the pending legalization of recreational cannabis in Canada, the data acquired by Strainprint also holds significance in determining many facets of regulations concerning public health and safety," he added.
"StrainprintTM was created out of necessity. As a patient who had limited knowledge about cannabis, the need for a tool to help guide and enhance treatment seemed almost essential. It didn't exist, and that's why we spent several years developing it. We're continually improving the software to ensure a simple and rewarding experience," said Stephanie Karasick, Founder & Chief Strategy Officer.
A new version of the APP will be released in the coming weeks with an exciting Loyalty Program, where users can redeem accumulated points for cannabis-related products and merchandise.
Learn more about Strainprint at: www.strainprint.ca
Connect with Strainprint on Facebook: www.facebook.com/strainprint
Follow us on Twitter: twitter.com/strainprint 
Tweet: Strainprint Launches revolutionary mobile app for cannabis patients. #strainprint
About StrainprintTM:
Founded in 2016, StrainprintTM Technologies Ltd. is a Toronto-based company providing enterprise grade analytics and consumer solutions for the medical cannabis industry. StrainprintTM manages the gathering and analysis of real-time cannabis consumption data and ranks specific strain efficacy against conditions and related symptoms. Analyzing anonymous patient treatment data and efficacy measures will help to identify new treatment protocols for the medical community and patients. StrainprintTM also works with commercial producers and clinics to provide advanced intelligence to optimize grow operations and treatment methods.
Media Contact:
Alexander E. Repetski, CCO
Strainprint Technologies Ltd.
647.282.3825

Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video


 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


World's First Marijuana ETF Launched; Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ)

World's First Marijuana ETF Launched; Horizons Medical Marijuana Life Sciences ETF (TSX: HMMJ)
Horizons Medical Marijuana Life Sciences ETF Begins Trading on the TSX

TORONTO - April 5, 2017 (Investorideas.com Newswire) Horizons ETFs Management (Canada) Inc. ("Horizons ETFs") is pleased to announce the launch of the Horizons Medical Marijuana Life Sciences ETF ("HMMJ"). Units of the exchange traded fund ("ETF") begin trading on the Toronto Stock Exchange ("TSX") today under the ticker symbol HMMJ.
HMMJ is the first ETF in the world that offers direct exposure to North American-listed stocks that are involved with medical marijuana bioengineering and production.
"Canada is the birthplace of ETFs and has been home to many firsts in the industry. The Horizons Medical Marijuana Life Sciences ETF is another made-in-Canada ETF milestone, the world's first marijuana ETF," said Steve Hawkins, President and Co-CEO of Horizons ETFs. "At Horizons, we take pride in our innovation, so we're very happy that for the first time, investors will be able to access a low-cost, diversified portfolio of companies that are directly involved in the rapidly growing medical marijuana industry."
HMMJ is an index (or passively managed) ETF, which seeks to replicate, to the extent possible, the performance of Solactive's North American Medical Marijuana Index ("the Index"), net of expenses. The Index provides exposure to the performance of a basket of North American publicly listed life sciences companies, and other firms, with significant business activities in the marijuana industry. The Index selects from a current universe of companies that have operations that may include one or more of biopharmaceuticals, medical manufacturing, distribution, bioproducts and other ancillary businesses, related to the marijuana industry.
Only stocks that meet minimum asset and liquidity thresholds are eligible for inclusion in the Index. Stocks are rebalanced quarterly on a market-capitalization basis, and capped so that no single stock can exceed 10% of the weight of the Index when rebalanced.
The following table of securities shows the current weights of the Index as at March 17, 2017. HMMJ may not necessarily hold all of the securities in the Index. If Horizons ETFs becomes aware that one or more constituent issuers of HMMJ's Index conduct activities in violation of applicable laws, including state or federal legislation in the United States, HMMJ will not hold the securities of those constituent issuers, notwithstanding their inclusion in the Index.


"The rapid growth of the medical marijuana industry, which includes the growth in the size of companies and the number of companies that are publicly listed on North American stock exchanges, has created enough market depth and liquidity to make launching an ETF with this unique theme possible," said Mr. Hawkins. "It's rare that investors get an opportunity to invest in what is essentially an entirely new sector of stocks. Despite the recently strong performance of many of these companies, we do think that we're still in the early stages of what could be a unique long-term growth opportunity."
HMMJ has closed its initial offering of units and will begin trading on the TSX when the market opens this morning.
About Solactive (www.solactive.com)
Solactive AG is an innovative index provider that focuses on the development, calculation and distribution of tailor-made indices over all asset classes. As of January 2017, Solactive AG served approximately 350 clients in Europe, America and Asia, with approximately USD $100 billion invested in products linked to indices calculated by the Company globally, primarily via 250 exchange traded funds from a number of well-known providers. Solactive AG was established in 2007 and is headquartered in Frankfurt.
About Horizons ETFs Management (Canada) Inc. (www.HorizonsETFs.com)
Horizons ETFs Management (Canada) Inc. and its affiliate AlphaPro Management Inc. are innovative financial services companies offering the Horizons ETFs family of exchange traded funds. The Horizons ETFs family includes a broadly diversified range of investment tools with solutions for investors of all experience levels to meet their investment objectives in a variety of market conditions. Horizons ETFs has more than $7 billion of assets under management. With 77 ETFs listed on the Toronto Stock Exchange, the Horizons ETFs family makes up one of the largest families of ETFs in Canada. Horizons ETFs Management (Canada) Inc. and AlphaPro Management Inc. are members of the Mirae Asset Global Investments Group.
Commissions, management fees and applicable sales taxes all may be associated with an investment in the exchange traded funds managed by Horizons ETFs Management (Canada) Inc. (the "ETFs"). The ETFs are not guaranteed, their values change frequently and past performance may not be repeated. The prospectus contains important detailed information about the ETFs. Please read the prospectus before investing.
Certain statements contained in this news release constitute forward-looking information within the meaning of Canadian securities laws. Forward-looking information may relate to a future outlook and anticipated distributions, events or results and may include statements regarding future financial performance. In some cases, forward-looking information can be identified by terms such as "may", "will", "should", "expect", "anticipate", "believe", "intend" or other similar expressions concerning matters that are not historical facts. Actual results may vary from such forward-looking information. Horizons ETFs undertakes no obligation to update publicly or otherwise revise any forward-looking statement whether as a result of new information, future events or other such factors which affect this information, except as required by law.
HMMJ is not sponsored, promoted, sold or supported in any other manner by Solactive AG nor does Solactive AG offer any express or implicit guarantee or assurance either with regard to the results of using the Index and/or Index trade name or the Index Price at any time or in any other respect. The Index is calculated and published by Solactive AG. Solactive AG uses its best efforts to ensure that the Index is calculated correctly. Irrespective of its obligations towards the Issuer, Solactive AG has no obligation to point out errors in the Index to third parties including but not limited to investors and/or financial intermediaries of the financial instrument. Neither publication of the Index by Solactive AG nor the licensing of the Index or Index trade name for the purpose of use in connection with the financial instrument constitutes a recommendation by Solactive AG to invest capital in HMMJ nor does it in any way represent an assurance or opinion of Solactive AG with regard to any investment in HMMJ.
SOURCE Horizons ETFs Management (Canada) Inc.
For further information:
For investor inquiries: 1-866-641-5739 (toll-free) or (416) 933-5745, info@horizonsetfs.com; For press or other inquiries: Mark Noble, Head of Sales Strategy, Horizons ETFs Management (Canada) Inc., (416) 640-8254, mnoble@horizonsetfs.com
RELATED LINKS www.horizonsetfs.com


Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video
 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.


NCIA Announces 4th Annual Cannabis Business Summit® & Expo

NCIA Announces 4th Annual Cannabis Business Summit® & Expo
Award-Winning Cannabis Industry Trade Show Returns to San Francisco Bay in June

OAKLAND, CA - April 5, 2017 (Investorideas.com Newswire) The National Cannabis Industry Association (NCIA), the only national trade association representing the businesses of the legal marijuana industry, will hold its 4th annual Cannabis Business Summit® & Expo at the Oakland Marriott City Center in Oakland, CA, June 12-14, 2017. As California prepares to launch the world's largest adult-use cannabis market, other states establish or evolve their own programs, and questions remain about the future of federal marijuana policy, NCIA's flagship event will prepare cannabis professionals for the opportunities and challenges ahead.
The Cannabis Business Summit® & Expo is the most influential cannabis business trade show in the U.S., hosted in the epicenter of the cannabis movement by the industry's only national trade association. Named 2016's Best Business Event by The Denver Post's Cannabist and one of Trade Show Executive's Fastest 50 Growing Trade Shows of 2016, NCIA's largest event of the year brings together the industry's brightest and best minds to provide attendees with high-value, curated educational programs, including personalized, hands-on workshops, a five-track general summit, and innovative, peer-reviewed presentations.
Following the momentous 2016 election, the theme of this year's Cannabis Business Summit® & Expo is "Cultivating a New Era of Enterprise", The Summit strives to prepare the cannabis industry with best practices and methods to succeed in the ever-changing regulatory environment, to strengthen the cannabis community's collective voice, and to advocate for cannabis policy and reform at the national level. NCIA invites all current, new, and prospective cannabis professionals to learn, network, and make their voices heard at the 2017 Cannabis Business Summit® & Expo.
Pre-Summit activities on June 12 include:
  • Full-day workshop - The Cannabis Conservancy Presents: From Roots to Fruits: Building Resiliency for Farms, Manufacturers, Distributors, and Dispensaries
  • Full-day boot camp - Starting and Operating a Successful Medical Cannabis Dispensary, Cultivation, or Infused Products Company
  • Continuing Legal Education session with the National Cannabis Bar Association
  • Intimate, behind-the-scenes cannabis business tours
General Summit activities on June 13-14 include:
  • Opening remarks by NCIA executive director Aaron Smith
  • Keynote speakers from experts in business and policy
  • More than 80,000 square feet of sold-out expo floor
  • Five educational session tracks:
    • The Fine Print: Money, Law, and Your Business
    • Cultivation & Processing
    • Running Your CannaBusiness
    • Policy & Reform
    • Leading Edge: Emerging Topics in the Cannabis Industry
  • Networking reception
  • Official NCIA after-party
Additional Cannabis Business Summit® & Expo agenda details are being released throughout this month. Those interested should follow NCIA on Facebook (@TheNCIA) and Twitter (@NCIAorg), or sign up online (CannabisBusinessSummit.com/Oakland-2017/Agenda) to receive the latest information.
NCIA's Cannabis Business Summit® & Expo 2017 is expected to sell out with more than 4,500 attendees. Potential attendees are urged to purchase Conference and Expo Passes as soon as possible at CannabisBusinessSummit.com or by calling (888) 409-4419. Prices for Summit registration will increase after March 24.
Representing more than 1,000 member-businesses nationwide, the National Cannabis Industry Association (NCIA) is the largest cannabis trade association in the U.S. and the only organization representing cannabis-related businesses at the national level. NCIA promotes the growth of a responsible and legitimate cannabis industry and works toward a favorable social, economic, and legal environment for that industry in the United States.


Like Marijuana Stocks? View our Marijuana / Hemp Stocks Directory
Global Cannabis Investing - features Investor Ideas Cannabis news



Watch the 420 Cannabis Investor video
 

More Info:

This news is published on the Investorideas.com Newswire - a global digital news source for investors and business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investment involves risk and possible loss of investment. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Contact each company directly regarding content and press release questions. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info regarding BC Residents and global Investors: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894. Global investors must adhere to regulations of each country.